on 15 Jan 2025
Last Applicant/ Owned by
ViroPharma Biologics LLC
300 Shire WayLexington, MA 02421
US
Serial Number
2114306 filed on 16th Jun 2021
Correspondent Address
GOWLING WLG (CANADA) LLP
SUITE 2600, 160 ELGIN STREETOTTAWA
ONTARIO
CA
K1P1C3
Trademark usage description
pharmaceutical products, namely, budesonide oral suspension (bos) for eosinophilic esophagitis (eoe).Vienna Information
1 . 15 . 15
DropsGouttes
26 . 1 . 1
CirclesCercles
26 . 1 . 3
One circle or ellipseUn cercle ou une ellipse
26 . 1 . 12
Circles or ellipses containing one or more other geometrical figures -- Note: Including circles or ellipses containing bent or straight lines (except 26.1.10).Cercles ou ellipses contenant une ou plusieurs autres figures géométriques -- Note: Y compris les cercles ou ellipses contenant des lignes courbées ou droites (excepté 26.1.10).
26 . 1 . 13
Circles or ellipses containing representations of heavenly bodies or natural phenomenaCercles ou ellipses contenant la représentation de corps célestes ou de phénomènes naturels
26 . 1 . 26
Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées
26 . 2 . 1
Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)
26 . 11 . 1
One line or one bandUne ligne ou une bande
26 . 11 . 11
Broken lines or bands (except a 26.11.13)Lignes ou bandes brisées (excepté a 26.11.13)
26 . 11 . 12
Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)
26 . 13 . 1
Stains, spots, blots, brush strokesTaches, coups de pinceau
11
2114306
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 42 on 15th Jan 2025 | Advertised |
Submitted for opposition 26 on 18th Dec 2024 | Approved |
Submitted for opposition 27 on 18th Dec 2024 | Approval Notice Sent |
Submitted for opposition 22 on 10th Dec 2024 | Search Recorded |
Submitted for opposition 287 on 5th Jul 2022 | Pre-Assessment Letter Sent |
Submitted for opposition 135 on 2th Nov 2021 | Amendment to Application |
Submitted for opposition 30 on 16th Jun 2021 | Filed |
Submitted for opposition 1 on 16th Jun 2021 | Created |
Submitted for opposition 31 on 16th Jun 2021 | Formalized |